Flexible Solutions International (FSI) investor relations material

Executive summary

• NCS division is shifting entirely to food grade products by end of 2026, focusing on food and nutraceuticals for growth.

• Panama division is taking over legacy industrial and agricultural products, aiming for shipping and tariff advantages for international sales.

• Two major food grade contracts were secured in 2025, with combined potential annual revenue exceeding $50 million.

• Major factory refurbishment in Illinois enabled new food grade contracts while maintaining profitability.

• New international agriculture and industrial product factory completed in Panama to support growth.

Financial highlights

• 2025 sales were $38.51 million, nearly flat compared to $38.23 million in 2024.

• Net profit for 2025 was $787,000 ($0.06/share), down from $3 million ($0.24/share) in 2024, due to ramp-up costs for new contracts and Panama factory.

• Operating cash flow (non-GAAP) was $5.54 million ($0.44/share), down from $7.08 million ($0.57/share) in 2024.

• Weighted average shares outstanding were 12.65 million in 2025 versus 12.45 million in 2024.

• Non-GAAP adjustments include depreciation, stock compensation, interest, investment income, and minority interest.

Outlook and guidance

• Significant revenue from the January 2025 food contract expected to be visible in Q2 2026.

• Full production for the second nutraceutical contract targeted for end of Q2 or early Q3 2026.

• Profits anticipated to increase rapidly in the second half of 2026 as ramp-up costs subside.

• ENP division expects low double-digit growth (10-12%) year-over-year in 2026.

• Growth expected in food and nutrition supplement manufacturing markets.